The GAIT Trial: Glucosamine-Chondroitin Hit Their Stride for Severe Osteoarthritis

Data from the long awaited Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT), one of the largest nutritional supplement studies ever undertaken, shows that while this combination of natural products did not offer too much help for patients with mild arthritis, it outperformed celecoxib (Celebrex) in people with the most severe disease.

The Content you are trying to see is available only for members of our site. If you already have a Membership you need to log in to see it. Please follow this link if you want to register.
 
Subscribe to Holistic Primary Care